CRWD Stock Surges 17% With 7-day Winning Spree On Morgan Stanley Upgrade
CrowdStrike (CRWD) – a cloud-delivered endpoint and identity protection subscription service – hit a 7-day winning streak, with cumulative gains over this period amounting to 17%. The company’s market cap has surged by about $16 Bil over the last 7 days and currently stands at $110 Bil.
The stock has YTD (year-to-date) return of 6.9% compared to -0.9% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Rally?
[1] Morgan Stanley Upgrade to Overweight
- Price target increased to $510 from $487
- Cited strong positioning in AI and module adoption
- Impact: Shares rose approximately 2% in premarket trading, Joined 70% of analysts with bullish ratings
[2] Strong Q4 2026 Earnings Report
- Beat revenue estimates with $1.31 billion
- Beat EPS estimates with $1.12
- Impact: Shares jumped 9.6% following the report, Multiple positive analyst rating affirmations
Opportunity or Trap?
Below is our take on valuation.
There is not much to fear in CRWD stock given its overall Strong operating performance and financial condition. But given its Very High valuation, the stock appears Relatively Expensive (For details, see Buy or Sell CRWD).
But here is the real interesting point.
You are reading about this 17% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that have not surged yet.
Returns vs S&P 500
The following table summarizes the return for CRWD stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | CRWD | S&P 500 |
|---|---|---|
| 1D | 0.5% | -0.2% |
| 7D (Current Streak) | 17.3% | -1.4% |
| 1M (21D) | 10.3% | -2.2% |
| 3M (63D) | -14.8% | -1.3% |
| YTD 2026 | -6.9% | -0.9% |
| 2025 | 37.0% | 16.4% |
| 2024 | 34.0% | 23.3% |
| 2023 | 142.5% | 24.2% |
However, big gains can follow sharp reversals – but how has CRWD behaved after prior drops? See CRWD Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 10 S&P constituents with 3 days or more of consecutive gains and 101 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 6 | 37 |
| 4D | 0 | 31 |
| 5D | 2 | 5 |
| 6D | 0 | 9 |
| 7D or more | 2 | 19 |
| Total >=3 D | 10 | 101 |
Key Financials for CrowdStrike (CRWD)
Last 2 Fiscal Years:
| Metric | FY2025 | FY2026 |
|---|---|---|
| Revenues | $4.0 Bil | $4.8 Bil |
| Operating Income | $-116.4 Mil | $-293.3 Mil |
| Net Income | $-15.2 Mil | $-162.5 Mil |
Last 2 Fiscal Quarters:
| Metric | 2026 FQ3 | 2026 FQ4 |
|---|---|---|
| Revenues | $1.2 Bil | $1.3 Bil |
| Operating Income | $-69.4 Mil | $13.8 Mil |
| Net Income | $-34.0 Mil | $59.4 Mil |
While CRWD stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.